COMMUNIQUÉS West-GlobeNewswire

Tenaya Therapeutics Announces Proposed Public Offering
11/12/2025
SOUTH SAN FRANCISCO, Calif., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (Nasdaq: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative [...]
Nusano Receives “Best Companies to Work For” Award from Utah Business
11/12/2025
State’s top workplaces identified by employee survey data WEST VALLEY CITY, Utah, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Nusano, physics company working to transform radioisotope production and enable industries ranging from [...]
Kestra Medical Technologies Reports Second Quarter Fiscal 2026 Financial Results
11/12/2025
KIRKLAND, Wash., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a wearable medical device and digital healthcare company, today reported financial results for the second quarter [...]
Tenaya Therapeutics Reports Positive Interim Data from Cohort 1 of RIDGE™-1 Phase 1b/2 Clinical Trial of TN-401 Gene Therapy for Adults with PKP2-associated ARVC
11/12/2025
TN-401 was Well Tolerated at 3E13 vg/kg dose Robust Transduction and Demonstrated Increases in PKP2 Protein Levels in First Two Patients at Week 8 Clinically Meaningful Reductions in Arrhythmia Burden Observed in First [...]
Structure Therapeutics Announces Closing of Upsized $747.5 Million Public Offering of ADSs and Pre-Funded Warrants and Full Exercise of the Underwriters’ Option to Purchase Additional ADSs
11/12/2025
SAN FRANCISCO, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic diseases, [...]
Oruka Therapeutics Announces New Board Member and Board Transition
11/12/2025
Appoints accomplished commercial leader Chris Martin to its Board of Directors MENLO PARK, Calif., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Oruka Therapeutics, Inc. (“Oruka”) (Nasdaq: ORKA), a clinical-stage biotechnology [...]
Kymera Therapeutics Announces Closing of Upsized $602 Million Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
11/12/2025
WATERTOWN, Mass., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological [...]
Tenaya Therapeutics Announces Rapid Resolution and Lifting of Clinical Hold for MyPEAK-1™ Phase 1b/2a Clinical Trial of TN-201 Gene Therapy
11/12/2025
MyPEAK-1 Protocol Amendments Agreed Upon with FDA; Tenaya Implementing Changes with Sites SOUTH SAN FRANCISCO, Calif., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage [...]
Zealand Pharma increases its share capital as a result of the exercise of employee warrants
11/12/2025
Company announcement – No. 25 / 2025 Zealand Pharma increases its share capital as a result of the exercise of employee warrants Copenhagen, Denmark, December 11, 2025 – Zealand Pharma A/S (“Zealand Pharma”) (NASDAQ: [...]
Health Care Advocates Slam Ford Government for Privatizing Surgeries While Pushing Public Hospitals into Deficit
11/12/2025
“A gross misuse of public funds” the Coalition warns as mass protests are planned TORONTO, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Ontario’s public hospitals have been pushed into deficit and ordered to find cuts while the [...]
Tevogen CEO Supports Local Law Enforcement with Personal Contribution of 230,000 Company’s Shares of Common Stock
11/12/2025
WARREN, N.J., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN ), today announced that its Founder and CEO, Dr. Ryan Saadi has donated 230,000 of his personal shares of [...]
Celcuity Presents Updated Results from the PIK3CA Wild-Type Cohort of the Phase 3 VIKTORIA-1 Trial at the 2025 San Antonio Breast Cancer Symposium
11/12/2025
For patients whose time to progression on immediate prior therapy was >18 months, median progression-free survival (“PFS”) was 12.4 months with gedatolisib + palbociclib + fulvestrant (“gedatolisib triplet”) and 10.0 [...]
Vitally Important: National Women’s Health Summit Tickets On Sale Now
11/12/2025
Limited quantity available – secure your spot for the inaugural summit on women’s health today. Early-bird pricing available until January 23 TORONTO, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Tickets are now on sale for [...]
Les billets sont maintenant en vente pour Importance Vitale : sommet national sur la santé des femmes
11/12/2025
Places limitées – réservez votre place dès aujourd’hui pour le sommet inaugural sur la santé des femmes. Tarif préférentiel jusqu'au 23 janvier TORONTO, 11 déc. 2025 (GLOBE NEWSWIRE) -- Les billets sont maintenant en [...]
Hypersante Introduces the 2026 Longevity and Biohacking Summit in Paris
11/12/2025
Announces the launch news of the summit, helping to capture interest around longevity and biohacking trends. Paris, France, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Hypersanté , a leading organisation in longevity, biohacking [...]
Merakris Therapeutics Chief Scientific Officer Dr. Roger Ilagan to Present at Innovations in Wound Healing Symposium
11/12/2025
RESEARCH TRIANGLE PARK, N.C., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Merakris Therapeutics, a regenerative medicine company developing biologic drug therapies for hard-to-heal wounds, announces that Chief Scientific Officer [...]
SEMCAP Health Leads $25 Million Series D Investment in SafeinHome
11/12/2025
WALNUT CREEK, Calif., Dec. 11, 2025 (GLOBE NEWSWIRE) -- SafeinHome , the nation’s leader in Remote Supports for individuals with intellectual and developmental disabilities (I/DD), today announced the successful first [...]
Hundreds Gather in Seattle in Support of Increasing Access to Mental Health Services in King County at SOUND Behavioral Health’s Annual SOUND of Hope Gala
11/12/2025
Second Annual Gala Fundraiser Exceeds SOUND’s Fundraising Goal to Help Open More Doors to Mental Health and Substance Abuse Services SEATTLE, Dec. 11, 2025 (GLOBE NEWSWIRE) -- In late November more than 400 community [...]
MAIA’s Ateganosine Surges Ahead with Breakthrough Momentum as Pivotal Phase 3 Trial Initiates
11/12/2025
CHICAGO, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Ateganosine (THIO, 6-thio-2'-deoxyguanosine), a first-in-class telomere-targeting therapy under development by MAIA Biotechnology (NYSE American: MAIA), appears to be gaining [...]

Pages